Drugs / DNV3837
last change Dec 2022 re-read 3 minutes ago

DNV3837

Developed for
Clostridium difficile colitis
Investigated by
Deinove

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03988855 Aug 2019 → Dec 2022 Clostridium difficile colitis Deinove Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DNV3837 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03988855 ↗
Route Intravenous “administered via IV infusion” NCT03988855 ↗